About this trial
The purpose of this project is to examine the feasibility/acceptability of a one-day Acceptance and Commitment Therapy + Lifestyle Education group intervention paired with 12-weeks of Continuous Glucose Monitoring for patients with type 2 diabetes (T2D) living in rural communities. This study is being designed as a randomized control trial (RCT) comparing ACT+LE+CGM to LE+CGM to LE. The ultimate goal of this line of research is that a community-wide intervention of Acceptance and Commitment Therapy (ACT) with Continuous Glucose Monitoring (CGM) and Lifestyle Education (LE) will improve T2D outcomes in rural communities compared to CGM and LE, or LE alone. Our goal is to develop a scalable and sustainable program for diabetes management in rural areas that enables individual self-management and does not require extensive healthcare resources in an existing medical desert.
Eligibility criteria
Qualifiers
Diagnosed diabetes (self-reported) and with an HbA1c ≥ 6.0 (using point-of-care device)
at least 18 years of age or older
able to speak English
able to provide informed consent and participate in the study
Disqualifiers
Reported suicidal ideation at the initial visit
has evidence of acute psychosis that precludes informed consent
appears to be cognitively impaired to the extent that precludes informed consent
uses a heavy amount of alcohol or other substances
Trial design
Treatments tested in this trial
- Acceptance and Commitment Therapy
- Abbott FreeStyle® Libre® 3
- Generic Education
Treatment groups
Sponsors and collaborators
Sam Houston State University
Lead sponsor
Chelsea Ratcliff, Ph.D.
Collaborator
Owen Kelly, Ph.D.,RNutr
Collaborator
Oluwaseun Olaiya, DO
Collaborator
Michael Griffin, Ph.D.
Collaborator